Taurine compared to inhibitors of myeloperoxidase (MPO) as protective agents against low density lipoprotein  modification by enzymatically generated hypochlorous acid

H Kharazi; J Schaur

Journal of Kermanshah University of Medical Sciences

Peer-reviewed Medical Quarterly

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

Taurine compared to inhibitors of myeloperoxidase (MPO) as protective agents against low density lipoprotein modification by enzymatically generated hypochlorous acid

Author(s):

H Kharazi^1,*,

J Schaur²

1Iran

2Austria

Journal of Kermanshah University of Medical Sciences:Vol. 7, issue 2; e81206

Published online:Sep 19, 2003

Article type:Research Article

Received:Apr 12, 2003

Accepted:Aug 15, 2003

How to Cite:Kharazi H, Schaur J. Taurine compared to inhibitors of myeloperoxidase (MPO) as protective agents against low density lipoprotein modification by enzymatically generated hypochlorous acid. J Kermanshah Univ Med Sci. 2003;7(2):e81206. doi:

Abstract

Background & Objective: Taurine is a sulfur amino acid that protects cells from self-destruction during oxidative processes, such as chlorinated oxidants (hypochlorous acid, HOCl). Our objective was to compare the effects of taurine with myeloperoxidase inhibitors (MPO) on the process of HOCL-induced low density lipoprotein (LDL) changes.

Materials & Methods: We assessed the serum of some blood donors with normal serum lipid levels. We evaluated 1) blocking the neutrophil function by preventing oxidant production by MPO with 3-amino 1,2,4 triazole, potassium cyanide, sodium azide, P-hydroxy-benzoic acid hydrazide (pHBAH), Salicylhydroxamic acid, and benzohydroxarnic acid; 2) trapping of products of activated neutrophils,such as MPO- derived HOCl by taurine , methionine and glycine. Tryptophan destruction in presence of the MPO system was monitored fluorimetrically as a marker of LDL modification.

Results: At a taurine concentration of 40 pM, which is three orders of magnitude below the physiological value, t_max2 was increased by a factor of 50 compared to the control in absence of taurine (20 min versus 0.4 min). P-hydroxy-benzoic acid hydrazide (pHBAH), at a concentration o f 0.3 to 0.75 MM, too, was a potent inhibitor of tryptophan destruction.

Discussion: This study suggests a high potential of taurine to slow down inflammatory processes by modulating the oxidative burst of neutrophils. Taurine was the second most potent netralizer of HOCL, after methionine. Taurine may be used to prevent oxidant damage to neutrophills.

Keywords

Fulltext

The full text of this article is available on PDF

Import into EndNote Import into BibTex

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 1 week ago
Scopus by Title: 0
Last Update: 1 week ago
Scopus by Title (Ref): 0
Last Update: 1 week ago
CrossRef: 0
Last Update: 5 days ago

Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

H Kharazi:[PubMed][Scholar]
J Schaur:[PubMed][Scholar]

Peer-reviewed Medical Quarterly

Outlines

Taurine compared to inhibitors of myeloperoxidase (MPO) as protective agents against low density lipoprotein modification by enzymatically generated hypochlorous acid

Abstract

Fulltext

Last Update: 1 week ago

Last Update: 1 week ago

Last Update: 1 week ago

Last Update: 5 days ago